Two Sigma Securities LLC acquired a new stake in Express Scripts (NASDAQ:ESRX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,442 shares of the company’s stock, valued at approximately $406,000.
Several other large investors also recently made changes to their positions in the stock. SeaCrest Wealth Management LLC acquired a new position in shares of Express Scripts in the 4th quarter worth approximately $105,000. Aevitas Wealth Management Inc. acquired a new position in Express Scripts during the 4th quarter valued at approximately $128,000. Financial Gravity Companies Inc. acquired a new position in Express Scripts during the 4th quarter valued at approximately $142,000. Bank of Nova Scotia Trust Co. acquired a new position in Express Scripts during the 3rd quarter valued at approximately $120,000. Finally, Monroe Bank & Trust MI boosted its position in Express Scripts by 74.8% during the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares during the period. Institutional investors and hedge funds own 89.44% of the company’s stock.
Shares of NASDAQ ESRX opened at $67.88 on Friday. The company has a current ratio of 0.67, a quick ratio of 0.55 and a debt-to-equity ratio of 0.83. Express Scripts has a one year low of $55.80 and a one year high of $85.07. The stock has a market capitalization of $39,329.64, a price-to-earnings ratio of 9.56, a PEG ratio of 0.86 and a beta of 0.99.
Express Scripts (NASDAQ:ESRX) last issued its earnings results on Tuesday, February 27th. The company reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.07. The firm had revenue of $25.38 billion for the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.88 earnings per share. equities research analysts anticipate that Express Scripts will post 9.35 EPS for the current fiscal year.
Express Scripts declared that its board has approved a stock repurchase plan on Monday, December 18th that permits the company to repurchase 45,000,000 shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.
A number of research analysts recently issued reports on ESRX shares. BidaskClub upgraded Express Scripts from a “hold” rating to a “buy” rating in a research report on Thursday, December 14th. Maxim Group boosted their price target on Express Scripts from $78.00 to $87.00 and gave the stock a “buy” rating in a research report on Thursday, December 14th. SunTrust Banks set a $82.00 price target on Express Scripts and gave the stock a “buy” rating in a research report on Thursday, December 14th. Robert W. Baird upgraded Express Scripts from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $72.00 to $81.00 in a research report on Friday, December 15th. Finally, Raymond James Financial reissued a “sell” rating on shares of Express Scripts in a research note on Friday, December 15th. Three equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $81.97.
In related news, insider Christine Houston sold 19,889 shares of the business’s stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $76.69, for a total transaction of $1,525,287.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction dated Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the transaction, the vice president now directly owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,233 shares of company stock valued at $2,173,054. 0.68% of the stock is currently owned by corporate insiders.
WARNING: “5,442 Shares in Express Scripts (NASDAQ:ESRX) Purchased by Two Sigma Securities LLC” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/07/5442-shares-in-express-scripts-holding-esrx-purchased-by-two-sigma-securities-llc.html.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.